
Chinese drug maker Akeso hailed as biotech’s ‘DeepSeek moment’ amid US competition
Chinese drug maker Akeso, whose new cancer drug has outperformed a leading Western peer in clinical studies, is being hailed as the “DeepSeek moment” for China’s drug industry, as biotech emerges as a new front in the escalating US-China tech war. Akeso’s …